Aromatase as a target for treating endometriosis
review
OA: closed
CC0
⤵ 25 in-corpus citations
AI-generated summary
This review outlines the role of aromatase in estrogen production in endometriosis and proposes novel therapeutic strategies targeting this enzyme.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a common gynecological disease that causes various clinical symptoms, such as chronic pelvic pain, dysmenorrhea and infertility, seriously affecting women's health and their quality of life. The symptoms and endometriotic lesions are relieved, in many cases, after menopause, when estrogen levels are lowered. Therefore, endometriosis is considered to be estrogen-dependent. Aromatase, the enzyme responsible for the last step of estrogen biosynthesis converting testosterone and androgen to estrogen, was previously reported to be more abundant in endometriotic tissues than in the normal endometrium, leading to an increased local estrogen concentration. Therefore, aromatase is considered a key therapeutic target for regulating local estrogen biosynthesis in endometriosis. A more complete understanding of the mechanisms that modulate aromatase and its activity is required to develop novel estrogen-targeted therapies for endometriosis. In this review article, we outline the current understanding of the pathological processes involved in estrogen production in endometriosis and propose novel strategies to treat this disorder.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (72)
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis. via openalex
- Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis via openalex
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system via openalex
- Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
- Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β via openalex
- Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Dienogest reduces HSD17β1 expression and activity in endometriosis via openalex
- Endometrial and Endometriotic Concentrations of Estrone and Estradiol Are Determined by Local Metabolism Rather than Circulating Levels via openalex
- Endometriosis via openalex
- Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis via openalex
- ERβ- and Prostaglandin E2-Regulated Pathways Integrate Cell Proliferation via Ras-like and Estrogen-Regulated Growth Inhibitor in Endometriosis via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist via openalex
- New developments in the medical treatment of endometriosis via openalex
- Parthenolide reduces cell proliferation and prostaglandin estradiol synthesis in human endometriotic stromal cells and inhibits development of endometriosis in the murine model via openalex
- Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1α Enhances Local Estrogen Biosynthesis by Stimulating Aromatase Activity in Endometriosis via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- Regulation of Aromatase P450 Expression in Endometriotic and Endometrial Stromal Cells by CCAAT/Enhancer Binding Proteins (C/EBPs): Decreased C/EBP in Endometriosis Is Associated with Overexpression of Aromatase via openalex
- Regulation of Aromatase P450 Expression in Endometriotic and Endometrial Stromal Cells by CCAAT/Enhancer Binding Proteins (C/EBPs): Decreased C/EBPβ in Endometriosis Is Associated with Overexpression of Aromatase via openalex
- Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element via openalex
- Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element via openalex
- Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis via openalex
- Treatment of Endometriosis via openalex
- Treatment of pain associated with deep endometriosis: alternatives and evidence via openalex
- W2163315477 via openalex
- W2322133447 via openalex
- W2787941699 via openalex
- W4211081176 via openalex
- W4243625730 via openalex
- W4253042615 via openalex
- W2118205303 via openalex
- W1547162940 via openalex
- W1966947659 via openalex
- W1968872958 via openalex
- W1980385764 via openalex
- W1999582107 via openalex
- W2002196249 via openalex
- W2008632158 via openalex
- W2009256907 via openalex
- W2015065898 via openalex
- W2021687464 via openalex
- W2046640023 via openalex
- W2047317603 via openalex
- W2049619918 via openalex
- W2054885202 via openalex
- W2057939468 via openalex
- W2065460036 via openalex
- W2066645560 via openalex
- W2068935255 via openalex
- W2075019139 via openalex
- W2076358748 via openalex
- W2086235375 via openalex
- W2089914596 via openalex
- W2090871122 via openalex
- W2091969987 via openalex
- W2103212783 via openalex
- W1020171890 via openalex
- W2126100083 via openalex
- W2136357797 via openalex
- W2141789735 via openalex
- W2142906190 via openalex
- W2153056118 via openalex
- W2163168485 via openalex
Cited by (26)
- Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report 2026
- D-chiro-inositol effectively counteracts endometriosis in a mouse model 2025
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway 2024
- Gene expression of aromatase, SF-1, and HSD17B2 in menstrual blood as noninvasive diagnostic biomarkers for endometriosis 2024
- Circulating estradiol and its biologically active metabolites in endometriosis and in relation to pain symptoms 2023
- Xiaoyi Yusi decoction improves fertilization and embryo transfer outcomes in patients with endometriosis 2023
- Evaluation of aromatase expression in endometrioid heterotopias and endometria in patients with external genital endometriosis 2023
- COX isozymes and non-uniform neoangiogenesis: What is their role in endometriosis? 2023
- Research advances in endometriosis-related signaling pathways: A review 2023
- SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell via Balancing ERα and PR Signals 2022
- SCM-198 Prevents Endometriosis By Reversing Low Autophagy Levels Of Endometriotic Stromal Cells Via Inhibiting TNF-Α-Aromatase-Estrogen-Erα Pathway And Promoting PR Expression 2022
- Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems 2022
- The Role of Aromatase Enzyme in Hormone Related Diseases and Plant-Based Aromatase Inhibitors as Therapeutic Regimens 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Elagolix Sodium: Novel GnRH Antagonist for the Treatment of Endometriosis 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis—Current Opinion and Future Perspectives 2021
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer 2020
- Discerning Endometriosis as a Multifaceted Entity: A Comprehensive Review 2020
- Endometriosis and ovarian cancer - what they have in common? 2020
- Immunohistochemical expression of estrogen receptor α, Bcl‐2 and <scp>NF‐κB P65</scp> in the polyps of patients with and without endometriosis 2020
- Clotrimazole reduces endometriosis and the estrogen concentration by downregulating aromatase 2020
- Adenomyosis: genetics of estrogen metabolism 2019
- Postmenopausal endometriosis, where are we now? 2019
- Hormonal Therapy in Women of Reproductive Age with Endometriosis: an Update 2019
Source provenance
- europepmc
- last seen: 2026-06-22T06:15:23.361955+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:37.156494+00:00
License: CC0
· commercial use OK